REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Scope & Guideline

Advancing knowledge in endocrine health.

Introduction

Delve into the academic richness of REVIEWS IN ENDOCRINE & METABOLIC DISORDERS with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1389-9155
PublisherSPRINGER
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 2000 to 2024
AbbreviationREV ENDOCR METAB DIS / Rev. Endocr. Metab. Disord.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, NY 10004, UNITED STATES

Aims and Scopes

The journal 'Reviews in Endocrine & Metabolic Disorders' focuses on the intricate relationships between endocrine functions and metabolic disorders, providing a platform for comprehensive reviews that integrate clinical, experimental, and translational research. Its core aims are to advance understanding in various areas related to endocrinology and metabolism, emphasizing novel insights and therapeutic strategies.
  1. Endocrine Disorders and Their Management:
    The journal covers a wide range of endocrine disorders, including diabetes, thyroid diseases, and adrenal conditions, emphasizing diagnosis, treatment modalities, and management strategies.
  2. Metabolic Disorders and Interventions:
    It focuses on metabolic disorders such as obesity, metabolic syndrome, and their complications, providing insights into pathophysiology and potential therapeutic interventions.
  3. Translational Research and Clinical Applications:
    The journal emphasizes the translation of basic research findings into clinical practice, highlighting the implications of endocrine and metabolic research on patient care.
  4. Systematic Reviews and Meta-Analyses:
    A significant portion of the content includes systematic reviews and meta-analyses, summarizing evidence-based approaches for various endocrine and metabolic conditions.
  5. Emerging Therapeutics and Novel Approaches:
    The journal often features articles on emerging therapies, including pharmacological treatments, lifestyle interventions, and innovative technologies in endocrinology and metabolism.
The journal has shown a dynamic evolution in its focus, with several themes emerging prominently in recent publications. These trends reflect current research interests and the ongoing challenges in the fields of endocrinology and metabolism.
  1. Precision Medicine in Endocrinology:
    A growing emphasis on precision medicine is evident, with research increasingly focusing on individualized treatment approaches tailored to genetic, phenotypic, and metabolic profiles.
  2. Impact of Gut Microbiota on Metabolism:
    Recent publications highlight the critical role of gut microbiota in metabolic disorders, linking microbiome health to obesity, diabetes, and other metabolic conditions.
  3. Neuroendocrine Interactions:
    There is an emerging interest in the interactions between neuroendocrine systems and metabolic health, exploring how neurological factors influence endocrine function and vice versa.
  4. Innovations in Diabetes Management:
    The journal has seen a rise in articles discussing innovative diabetes management strategies, including new pharmacological agents and technology-based interventions.
  5. Role of Inflammation in Endocrine Disorders:
    Research focusing on the inflammatory processes associated with endocrine disorders and their metabolic consequences is gaining traction, indicating a shift towards understanding the interplay between inflammation and metabolism.

Declining or Waning

While the journal addresses a wide array of topics, certain themes appear to be declining in prominence based on recent publication trends. These waning scopes suggest a shift in research focus or a diminishing interest in specific areas.
  1. Traditional Hormonal Therapies:
    There seems to be a reduced focus on traditional hormonal therapies for common endocrine disorders, possibly due to the emergence of newer, more targeted treatment options.
  2. Basic Science of Endocrine Mechanisms:
    Research centered solely on basic endocrine mechanisms without clinical implications appears to be less frequent, indicating a shift towards more applied and translational research.
  3. Aging and Endocrinology:
    Topics specifically addressing aging-related endocrine changes have become less prevalent, possibly overshadowed by more immediate clinical concerns and younger populations.
  4. Generalized Obesity Studies:
    The journal has moved away from generalized studies on obesity towards more specific phenotypes, metabolic impacts, and tailored interventions.
  5. Epidemiological Studies on Endocrine Disorders:
    There is a noticeable decline in purely epidemiological studies, suggesting a move towards more interventional and clinical research.

Similar Journals

METABOLISM-CLINICAL AND EXPERIMENTAL

Driving Discovery in Clinical Metabolism and Health
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0026-0495Frequency: 12 issues/year

METABOLISM-CLINICAL AND EXPERIMENTAL is a premier academic journal published by W B SAUNDERS CO-ELSEVIER INC, with a distinguished history dating back to 1952. This journal serves as a vital repository of knowledge in the fields of Endocrinology, Diabetes, and Metabolism, consistently ranking in the top quartile (Q1) within these categories according to the latest metrics. With an impressive impact factor and recognized for its contributions to Biochemistry, Genetics, and Molecular Biology, it ranks #5 out of 128 in the Scopus database for Endocrinology and #11 out of 244 for Medicine related to Endocrinology, Diabetes, and Metabolism, placing it in the 95th and 96th percentiles, respectively. While the journal does not currently offer open access, it maintains rigorous peer review standards and publishes cutting-edge research that drives forward the understanding of metabolic diseases and clinical practices. By engaging with METABOLISM-CLINICAL AND EXPERIMENTAL, researchers, healthcare professionals, and students can explore groundbreaking advancements and pivotal findings that shape the future of metabolic health.

HORMONE AND METABOLIC RESEARCH

Connecting Hormonal Dynamics to Metabolic Health
Publisher: GEORG THIEME VERLAG KGISSN: 0018-5043Frequency: 12 issues/year

HORMONE AND METABOLIC RESEARCH, published by GEORG THIEME VERLAG KG, stands as a reputable platform in the fields of biochemistry, endocrinology, and metabolism since its establishment in 1969. This peer-reviewed journal provides critical insights and advancements in the intricate relationships between hormones and metabolic processes, catering to researchers, healthcare professionals, and students alike. With an impressive convergence of knowledge spanning over five decades, it maintains a commendable Q3 ranking in multiple categories, including Biochemistry, Clinical Biochemistry, and Endocrinology, highlighting its contribution to cutting-edge scientific discourse. Although not an open-access journal, it offers a plethora of access options for readers and institutions, ensuring that vital research reaches those who need it most. Located in Stuttgart, Germany, the journal is positioned at the forefront of influential research in hormone and metabolic studies, emphasizing its importance for ongoing investigations into health and disease.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Unraveling the Complexities of Diabetes and Metabolism
Publisher: GEORG THIEME VERLAG KGISSN: 0947-7349Frequency: 10 issues/year

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES is a distinguished journal published by GEORG THIEME VERLAG KG, dedicated to advancing research and understanding in the fields of endocrinology, diabetes, and metabolism. With an ISSN of 0947-7349 and an E-ISSN of 1439-3646, this journal serves as a critical platform for disseminating high-quality research findings, reviews, and clinical studies from 1983 to 2024. The journal holds an impactful position within its respective categories, notably achieving Q3 in Endocrinology and Diabetes and Metabolism, and Q2 in Internal Medicine as per the 2023 category quartiles. Additionally, it ranks in the 57th and 46th percentiles in the Scopus rankings for Internal Medicine and Endocrinology, Diabetes and Metabolism, respectively. Though not an open-access publication, the journal caters to a global audience of researchers, professionals, and students, facilitating knowledge exchange and fostering collaboration within this vital area of medical science.

Hormones-International Journal of Endocrinology and Metabolism

Pioneering Insights into Diabetes and Metabolic Disorders
Publisher: SPRINGER INT PUBL AGISSN: 1109-3099Frequency: 4 issues/year

Hormones - International Journal of Endocrinology and Metabolism, published by Springer International Publishing AG, is a vital resource within the field of Endocrinology, Diabetes, and Metabolism. Since its inception in 2005, this journal has made significant contributions to the understanding of hormonal mechanisms and their implications across various medical disciplines. With a current impact factor that places it in the Q3 category for Endocrinology and the Q2 category for miscellaneous Medicine – as indicated by its Scopus rankings – it stands out as a reputable platform for cutting-edge research and clinical findings. Although it operates under a subscription model, the journal's comprehensive scope encompasses basic and applied scientific studies, making it essential reading for researchers, clinicians, and students alike. The journal is headquartered in Germany with a strong commitment to promoting scholarly communication and knowledge dissemination within its specialized fields through the year 2024 and beyond.

Turkish Journal of Endocrinology and Metabolism

Bridging Local Research with Global Health Solutions
Publisher: AVESISSN: 1301-2193Frequency: 4 issues/year

The Turkish Journal of Endocrinology and Metabolism, published by AVES, is a prominent platform dedicated to advancing research in the fields of endocrinology, diabetes, and metabolism. As an Open Access journal since 2002, it provides unrestricted access to its content, fostering a global exchange of knowledge among researchers, clinicians, and students. Operating from Turkey, this journal plays a crucial role in disseminating innovative findings related to endocrine disorders and metabolic diseases. While its current Q4 quartile rankings in both Endocrinology and Internal Medicine underscore areas for growth, they also signify the journal’s commitment to enhancing its impact within these disciplines. The journal emphasizes the development of locally relevant research while encouraging international contributions, thus bridging gaps in global health discourse. Engage with cutting-edge research that shapes clinical practices and informs public health policies by submitting your work or exploring the journal’s vast archive from 2009 to 2023.

ENDOCRINE JOURNAL

Advancing knowledge in endocrinology and metabolism.
Publisher: JAPAN ENDOCRINE SOCISSN: 0918-8959Frequency: 12 issues/year

ENDOCRINE JOURNAL, published by the Japan Endocrine Society, is a pivotal resource for researchers and professionals in the field of endocrinology, diabetes, and metabolism. With a long history dating back to 1954, this journal encompasses a comprehensive range of topics including hormonal regulation, pathophysiology of endocrine diseases, and innovative therapeutic approaches. Despite its classification as open access, the journal remains a beacon of knowledge, with impressive rankings—Q2 in Endocrinology, Diabetes and Metabolism and Q3 in Endocrinology for 2023—ensuring it is a respected source in the academic community. It serves as a critical platform for the dissemination of cutting-edge research, encouraging collaboration and facilitating advancements in understanding complex endocrine disorders. By subscribing to this journal, researchers and students gain access to seminal studies, clinical insights, and a wealth of information that drives this vital field forward.

Archives of Endocrinology Metabolism

Unveiling the latest breakthroughs in hormonal research.
Publisher: SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIAISSN: 2359-3997Frequency: 6 issues/year

Archives of Endocrinology Metabolism is a distinguished open-access journal dedicated to advancing the field of endocrinology and metabolism. Published by SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA, this journal has established itself as a vital platform for researchers, clinicians, and scholars since its inception in 2008. With an ISSN of 2359-3997 and E-ISSN of 2359-4292, it aims to disseminate high-quality research articles that explore the latest advancements in endocrinology, diabetes, and metabolism. As of 2023, it has achieved a commendable Q3 ranking in its field, demonstrating its relevancy and increasing visibility among peers. The journal's focus spans various sub-disciplines, including hormonal regulation, metabolic disorders, and innovative therapies, making it an essential resource for both emerging professionals and seasoned experts alike. With a rich repository of research from Brazil and beyond, Archives of Endocrinology Metabolism continuously seeks to contribute to the ongoing dialogue and collaboration within the global scientific community.

Cardiovascular Endocrinology & Metabolism

Unlocking the Connections Between Heart and Hormonal Health
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2574-0954Frequency: 4 issues/year

Cardiovascular Endocrinology & Metabolism is a leading open-access journal dedicated to advancing our understanding of the interconnections between cardiovascular health and endocrine functions. Published by Lippincott Williams & Wilkins, this journal serves as a vital resource for researchers and clinicians alike, providing timely insights into the intricate relationships between metabolic disorders and cardiovascular diseases. With an impressive impact factor and categorized in Q2 for both Cardiology and Cardiovascular Medicine as well as Endocrinology, Diabetes, and Metabolism, it holds a significant position within its respective fields. The journal has been fully open access since its inception in 2012, ensuring that critical research is accessible to a global audience. By fostering innovation and collaboration, Cardiovascular Endocrinology & Metabolism aims to promote better health outcomes and stimulate novel research directions, making it an essential resource for professionals striving to bridge the gaps between these two critical domains.

Journal of Endocrinology Metabolism and Diabetes of South Africa

Connecting researchers and practitioners for impactful findings.
Publisher: ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTDISSN: 1608-9677Frequency: 3 issues/year

Journal of Endocrinology Metabolism and Diabetes of South Africa, published by Routledge Journals, Taylor & Francis Ltd, serves as a vital platform for advancing research and knowledge dissemination in the fields of endocrinology, metabolism, and diabetes. Since its transition to Open Access in 2012, it has enabled greater accessibility to crucial findings and data, broadening its reach to researchers, practitioners, and students alike. Though its coverage in Scopus was discontinued in 2018, the journal continues to play an important role in fostering discourse in the medical community, as evidenced by its ranking within the 19th and 16th percentiles for Internal Medicine and Endocrinology, diabetes and metabolism, respectively. With its commitment to addressing pressing health issues in South Africa and beyond, this journal remains an invaluable resource for those seeking to understand and tackle the complexities of metabolic diseases.

Expert Review of Endocrinology & Metabolism

Your essential resource for breakthroughs in endocrinology.
Publisher: ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTDISSN: 1744-6651Frequency: 4 issues/year

Expert Review of Endocrinology & Metabolism is a premier journal dedicated to advancing the field of endocrinology and metabolism, published by Routledge Journals, Taylor & Francis Ltd, in the United Kingdom. With a robust focus on the latest research, innovative treatments, and clinical practices, this journal serves as an essential resource for healthcare professionals, researchers, and students seeking to stay abreast of developments in diabetes, obesity, thyroid disorders, and other endocrine-related conditions. Achieving a commendable Q2 status in Endocrinology, Diabetes, and Metabolism in the 2023 ranking, Expert Review of Endocrinology & Metabolism holds strong standing with an impressive Scopus rank, placing it at the 53rd percentile among its peers. The journal embraces a comprehensive approach, offering critical reviews, original research articles, and insights on emerging trends and technologies in the field. Although not an open-access journal, it provides extensive access options for subscribers and institutions, encouraging ease of dissemination and academic engagement. Through its commitment to high-quality content, Expert Review of Endocrinology & Metabolism remains pivotal for professionals aiming to enhance their understanding and practice in this vital area of medicine.